DxTerity Founder & CEO Bob Terbrueggen to present at Precision Medicine World Conference 2018
The Precision Medicine World Conference (PMWC) 2018 will take place in Silicon Valley on January 22-24, 2018. This year, we’re excited to announce that DxTerity Founder & CEO Bob Terbrueggen will be speaking at the conference. His talk, titled, “Genomic Monitoring of Lupus Patients. From Home” will be on Tuesday, January 23.
The thirteenth installment of this conference brings together innovators, thought leaders, global researchers, and medical professionals from across the healthcare and genomics sectors. Conference attendees will have the opportunity to learn about the latest developments and advancements in precision medicine from these 200+ speakers.
The conference is split into five tracks. Each track highlights a new strategy or solution that is changing the way patients are treated.
Track 1: Big Data Into the Clinic
Track 2: Immunotherapy
Track 3: Artificial Intelligence Showcase
Track 4: Emerging Tech Showcase
Track 5: Wellness and Aging Showcase
In his talk, “Genomic Monitoring of Lupus Patients. From Home.” DxTerity’s Bob Terbrueggen discusses how from-home genomic monitoring of immune-mediated diseases may help provide a better understanding of an individual’s health. The 1,300+ lupus participant LIFT Study demonstrates the ability to use self-collected fingerstick blood samples mailed from home, to cost-effectively monitor type 1 interferon levels and T-cell exhaustion markers in lupus.
Talk Title: Genomic monitoring of Lupus Patients. From Home.
Presenter: Bob Terbrueggen, Founder & CEO of DxTerity, a patient-centric genomics company
Date: DAY 2: Tuesday, Jan 23, 2018
Time: 1:45 – 2:00PM PST
Session: “Genomic Monitoring of Lupus Patients. From Home.” In Track 2 (Immunotherapy)